vs
MBIA INC（MBI）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
MBIA INC的季度营收约是ROCKWELL MEDICAL, INC.的1.5倍（$28.0M vs $18.3M），ROCKWELL MEDICAL, INC.净利率更高（-3.0% vs -182.1%，领先179.1%），MBIA INC同比增速更快（-24.3% vs -25.6%），过去两年MBIA INC的营收复合增速更高（46.8% vs -10.1%）
MBIA Inc.是一家美国金融服务企业，1973年以市政债券保险协会之名成立，总部位于纽约州帕切斯，是全球规模最大的债券保险公司，截至2015年1月共有约180名员工，深耕债券保险领域多年，在行业内拥有重要影响力。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
MBI vs RMTI — 直观对比
营收规模更大
MBI
是对方的1.5倍
$18.3M
营收增速更快
MBI
高出1.3%
-25.6%
净利率更高
RMTI
高出179.1%
-182.1%
两年增速更快
MBI
近两年复合增速
-10.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $28.0M | $18.3M |
| 净利润 | $-51.0M | $-554.0K |
| 毛利率 | — | 21.1% |
| 营业利润率 | -200.0% | -2.2% |
| 净利率 | -182.1% | -3.0% |
| 营收同比 | -24.3% | -25.6% |
| 净利润同比 | -106.1% | 26.7% |
| 每股收益（稀释后） | $-1.01 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MBIRMTI
| Q4 25 | $28.0M | $18.3M | ||
| Q3 25 | $15.0M | $15.9M | ||
| Q2 25 | $23.0M | $16.1M | ||
| Q1 25 | $14.0M | $18.9M | ||
| Q4 24 | $37.0M | $24.7M | ||
| Q3 24 | $29.0M | $28.3M | ||
| Q2 24 | $-37.0M | $25.8M | ||
| Q1 24 | $13.0M | $22.7M |
净利润MBIRMTI
| Q4 25 | $-51.0M | $-554.0K | ||
| Q3 25 | $-8.0M | $-1.8M | ||
| Q2 25 | $-56.0M | $-1.5M | ||
| Q1 25 | $-62.0M | $-1.5M | ||
| Q4 24 | $831.0M | $-756.0K | ||
| Q3 24 | $-56.0M | $1.7M | ||
| Q2 24 | $-254.0M | $343.0K | ||
| Q1 24 | $-86.0M | $-1.7M |
毛利率MBIRMTI
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
营业利润率MBIRMTI
| Q4 25 | -200.0% | -2.2% | ||
| Q3 25 | -46.7% | -9.9% | ||
| Q2 25 | -243.5% | -8.4% | ||
| Q1 25 | -442.9% | -7.2% | ||
| Q4 24 | -135.1% | -2.1% | ||
| Q3 24 | -175.9% | 6.8% | ||
| Q2 24 | 683.8% | 2.0% | ||
| Q1 24 | -669.2% | -5.8% |
净利率MBIRMTI
| Q4 25 | -182.1% | -3.0% | ||
| Q3 25 | -53.3% | -11.0% | ||
| Q2 25 | -243.5% | -9.3% | ||
| Q1 25 | -442.9% | -8.0% | ||
| Q4 24 | 2245.9% | -3.1% | ||
| Q3 24 | -193.1% | 5.9% | ||
| Q2 24 | 686.5% | 1.3% | ||
| Q1 24 | -661.5% | -7.6% |
每股收益（稀释后）MBIRMTI
| Q4 25 | $-1.01 | $-0.01 | ||
| Q3 25 | $-0.17 | $-0.05 | ||
| Q2 25 | $-1.12 | $-0.05 | ||
| Q1 25 | $-1.28 | $-0.04 | ||
| Q4 24 | $-1.07 | $-0.02 | ||
| Q3 24 | $-1.18 | $0.04 | ||
| Q2 24 | $-5.34 | $0.01 | ||
| Q1 24 | $-1.84 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $10.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-2.2B | $37.0M |
| 总资产 | $2.0B | $57.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MBIRMTI
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M | ||
| Q1 24 | — | $6.6M |
股东权益MBIRMTI
| Q4 25 | $-2.2B | $37.0M | ||
| Q3 25 | $-2.2B | $37.0M | ||
| Q2 25 | $-2.2B | $30.4M | ||
| Q1 25 | $-2.1B | $31.5M | ||
| Q4 24 | $-2.1B | $32.6M | ||
| Q3 24 | $-2.0B | $29.1M | ||
| Q2 24 | $-2.0B | $23.5M | ||
| Q1 24 | $-1.7B | $20.6M |
总资产MBIRMTI
| Q4 25 | $2.0B | $57.1M | ||
| Q3 25 | $2.1B | $57.5M | ||
| Q2 25 | $2.1B | $52.6M | ||
| Q1 25 | $2.1B | $54.0M | ||
| Q4 24 | $2.2B | $59.2M | ||
| Q3 24 | $2.2B | $57.1M | ||
| Q2 24 | $2.3B | $53.0M | ||
| Q1 24 | $2.5B | $50.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.0M | $2.3M |
| 自由现金流经营现金流 - 资本支出 | — | $2.2M |
| 自由现金流率自由现金流/营收 | — | 12.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.2M |
8季度趋势，按日历期对齐
经营现金流MBIRMTI
| Q4 25 | $38.0M | $2.3M | ||
| Q3 25 | $90.0M | $-1.3M | ||
| Q2 25 | $1.0M | $1.8M | ||
| Q1 25 | $-43.0M | $-3.5M | ||
| Q4 24 | $-176.0M | $865.0K | ||
| Q3 24 | $-139.0M | $4.3M | ||
| Q2 24 | $-10.0M | $1.4M | ||
| Q1 24 | $-30.0M | $-2.4M |
自由现金流MBIRMTI
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
自由现金流率MBIRMTI
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
资本支出强度MBIRMTI
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
现金转化率MBIRMTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.21× | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MBI
| US Public Finance Insurance | $15.0M | 54% |
| Corporate Operations | $7.0M | 25% |
| International And Structured Finance Insurance | $5.0M | 18% |
| Other | $1.0M | 4% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
